However, leptin is not the only factor at play in obesity tumour growth, highlighted by recent work in pancreatic adenocarcinoma mouse models demonstrating accelerated tumorigenesis in obese mice deficient in leptin signalling with the possible involvement of cholecystokinin [50]. Here, LEP is linked to obesity disorder.